Listed

Cardiol Therapeutics Inc.

CRDLNasdaqCIK 1702123HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Balance sheet

Cash and equivalentsCAD 21.4m, FY2025
Shareholders' equityCAD 17.9m, FY2025
Cardiol Therapeutics Inc., balance sheet, quarterly
Line itemUnitperiod not labelled2019-12-31period not labelled2020-12-31FY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Cash and equivalents$m7.0Cash and equivalents, period not labelled, at 2019-12-31CAD 7.0m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2023-03-29, accession 0001104659-23-037820.Report this figure14.0Cash and equivalents, period not labelled, at 2020-12-31CAD 14.0m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2024-04-01, accession 0001104659-24-041952.Report this figure83.9Cash and equivalents, FY2021, at 2021-12-31CAD 83.9m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2024-04-01, accession 0001104659-24-041952.Report this figure59.5Cash and equivalents, FY2022, at 2022-12-31CAD 59.5m. XBRL concept ifrs-full:CashAndCashEquivalents. 40-F filed 2025-03-31, accession 0001410578-25-000588.Report this figure34.9Cash and equivalents, FY2023, at 2023-12-31CAD 34.9m. XBRL concept ifrs-full:CashAndCashEquivalents. 40-F filed 2026-03-31, accession 0001104659-26-037844.Report this figure30.6Cash and equivalents, FY2024, at 2024-12-31CAD 30.6m. XBRL concept ifrs-full:CashAndCashEquivalents. 40-F filed 2026-03-31, accession 0001104659-26-037844.Report this figure21.4Cash and equivalents, FY2025, at 2025-12-31CAD 21.4m. XBRL concept ifrs-full:CashAndCashEquivalents. 40-F filed 2026-03-31, accession 0001104659-26-037844.Report this figure
Current assets$mnot reported14.9Current assets, period not labelled, at 2020-12-31CAD 14.9m. XBRL concept ifrs-full:CurrentAssets. 40-F/A filed 2022-04-20, accession 0001104659-22-047891.Report this figure87.1Current assets, FY2021, at 2021-12-31CAD 87.1m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2023-03-29, accession 0001104659-23-037820.Report this figure61.4Current assets, FY2022, at 2022-12-31CAD 61.4m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2024-04-01, accession 0001104659-24-041952.Report this figure36.2Current assets, FY2023, at 2023-12-31CAD 36.2m. XBRL concept ifrs-full:CurrentAssets. 40-F filed 2025-03-31, accession 0001410578-25-000588.Report this figure31.7Current assets, FY2024, at 2024-12-31CAD 31.7m. XBRL concept ifrs-full:CurrentAssets. 40-F filed 2026-03-31, accession 0001104659-26-037844.Report this figure23.5Current assets, FY2025, at 2025-12-31CAD 23.5m. XBRL concept ifrs-full:CurrentAssets. 40-F filed 2026-03-31, accession 0001104659-26-037844.Report this figure
Total assets$mnot reported15.9Total assets, period not labelled, at 2020-12-31CAD 15.9m. XBRL concept ifrs-full:Assets. 40-F/A filed 2022-04-20, accession 0001104659-22-047891.Report this figure87.9Total assets, FY2021, at 2021-12-31CAD 87.9m. XBRL concept ifrs-full:Assets. 20-F filed 2023-03-29, accession 0001104659-23-037820.Report this figure62.0Total assets, FY2022, at 2022-12-31CAD 62.0m. XBRL concept ifrs-full:Assets. 20-F filed 2024-04-01, accession 0001104659-24-041952.Report this figure36.7Total assets, FY2023, at 2023-12-31CAD 36.7m. XBRL concept ifrs-full:Assets. 40-F filed 2025-03-31, accession 0001410578-25-000588.Report this figure31.9Total assets, FY2024, at 2024-12-31CAD 31.9m. XBRL concept ifrs-full:Assets. 40-F filed 2026-03-31, accession 0001104659-26-037844.Report this figure23.6Total assets, FY2025, at 2025-12-31CAD 23.6m. XBRL concept ifrs-full:Assets. 40-F filed 2026-03-31, accession 0001104659-26-037844.Report this figure
Current liabilities$mnot reported2.5Current liabilities, period not labelled, at 2020-12-31CAD 2.5m. XBRL concept ifrs-full:CurrentLiabilities. 40-F/A filed 2022-04-20, accession 0001104659-22-047891.Report this figure11.6Current liabilities, FY2021, at 2021-12-31CAD 11.6m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2023-03-29, accession 0001104659-23-037820.Report this figure9.8Current liabilities, FY2022, at 2022-12-31CAD 9.8m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2024-04-01, accession 0001104659-24-041952.Report this figure8.3Current liabilities, FY2023, at 2023-12-31CAD 8.3m. XBRL concept ifrs-full:CurrentLiabilities. 40-F filed 2025-03-31, accession 0001410578-25-000588.Report this figure7.0Current liabilities, FY2024, at 2024-12-31CAD 7.0m. XBRL concept ifrs-full:CurrentLiabilities. 40-F filed 2026-03-31, accession 0001104659-26-037844.Report this figure5.7Current liabilities, FY2025, at 2025-12-31CAD 5.7m. XBRL concept ifrs-full:CurrentLiabilities. 40-F filed 2026-03-31, accession 0001104659-26-037844.Report this figure
Total liabilities$mnot reported2.6Total liabilities, period not labelled, at 2020-12-31CAD 2.6m. XBRL concept ifrs-full:Liabilities. 40-F/A filed 2022-04-20, accession 0001104659-22-047891.Report this figure11.6Total liabilities, FY2021, at 2021-12-31CAD 11.6m. XBRL concept ifrs-full:Liabilities. 20-F filed 2023-03-29, accession 0001104659-23-037820.Report this figure9.8Total liabilities, FY2022, at 2022-12-31CAD 9.8m. XBRL concept ifrs-full:Liabilities. 20-F filed 2024-04-01, accession 0001104659-24-041952.Report this figure8.5Total liabilities, FY2023, at 2023-12-31CAD 8.5m. XBRL concept ifrs-full:Liabilities. 40-F filed 2025-03-31, accession 0001410578-25-000588.Report this figure7.1Total liabilities, FY2024, at 2024-12-31CAD 7.1m. XBRL concept ifrs-full:Liabilities. 40-F filed 2026-03-31, accession 0001104659-26-037844.Report this figure5.7Total liabilities, FY2025, at 2025-12-31CAD 5.7m. XBRL concept ifrs-full:Liabilities. 40-F filed 2026-03-31, accession 0001104659-26-037844.Report this figure
Shareholders' equity$m14.7Shareholders' equity, period not labelled, at 2019-12-31CAD 14.7m. XBRL concept ifrs-full:Equity. 20-F filed 2023-03-29, accession 0001104659-23-037820.Report this figure13.3Shareholders' equity, period not labelled, at 2020-12-31CAD 13.3m. XBRL concept ifrs-full:Equity. 20-F filed 2024-04-01, accession 0001104659-24-041952.Report this figure76.2Shareholders' equity, FY2021, at 2021-12-31CAD 76.2m. XBRL concept ifrs-full:Equity. 20-F filed 2024-04-01, accession 0001104659-24-041952.Report this figure52.2Shareholders' equity, FY2022, at 2022-12-31CAD 52.2m. XBRL concept ifrs-full:Equity. 40-F filed 2025-03-31, accession 0001410578-25-000588.Report this figure28.2Shareholders' equity, FY2023, at 2023-12-31CAD 28.2m. XBRL concept ifrs-full:Equity. 40-F filed 2026-03-31, accession 0001104659-26-037844.Report this figure24.7Shareholders' equity, FY2024, at 2024-12-31CAD 24.7m. XBRL concept ifrs-full:Equity. 40-F filed 2026-03-31, accession 0001104659-26-037844.Report this figure17.9Shareholders' equity, FY2025, at 2025-12-31CAD 17.9m. XBRL concept ifrs-full:Equity. 40-F filed 2026-03-31, accession 0001104659-26-037844.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.